A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2004
11/10/2004	EP1261605B1 Benzoxazole derivatives as tnf and pde iv inhibitors
11/10/2004	EP1246793B1 Substituted aminomethyl-phenyl-cyclohexane derivatives
11/10/2004	EP1240172B1 New aminopropylphosphinic acids
11/10/2004	EP1198453B9 N-(indolcarbonyl-)piperazin derivatives
11/10/2004	EP1159258B1 Amide compounds for the potentiation of cholinergic activity
11/10/2004	EP1061901B1 Nicotine inhaler
11/10/2004	EP1027043B1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
11/10/2004	CN1545513A Novel 2H -pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
11/10/2004	CN1545512A Rapamycin dialdehydes
11/10/2004	CN1545511A Rapamycin 29-enols
11/10/2004	CN1545510A Quinazoline derivatives as alpha-1 adrenergic antagonists
11/10/2004	CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity
11/10/2004	CN1545422A Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingred
11/10/2004	CN1545416A Method of curing injured spinal cord and therapeutic agents for that
11/10/2004	CN1545415A Bone anabolic compounds and methods of use
11/10/2004	CN1545413A Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
11/10/2004	CN1545410A Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions
11/10/2004	CN1545407A Transdermal therapeutic system (TTS) with fentanyl as active ingredient
11/10/2004	CN1544945A Inhibition of Tau-Tau-association
11/10/2004	CN1544464A Peptides
11/10/2004	CN1544073A Chinese traditional medicine capable of invigorating yang and strengthening qi and its preparation
11/10/2004	CN1544053A Blood circulation promoting and pain alleviating soft capsule and its preparation
11/10/2004	CN1544051A Chinese traditional medicine for treating facial paralysis, facial spasm and trifacial neuralgia
11/10/2004	CN1544046A Chinese traditional medicine conditioning liquid for treating drug withdrawal sydrome and its preparation
11/10/2004	CN1544043A Bunao Yishen Runchang Capsule for replenishing brain and kidney and moistening intestines
11/10/2004	CN1544033A Freeze-dried powder injection of Qingkailing and its preparation process
11/10/2004	CN1544014A Oral liquid capable of relieving or neutralizing the effect of alcohol and its preparing method
11/10/2004	CN1543990A Chinese patent medicine for treating epilepsy
11/10/2004	CN1543970A Compositions of asiatic centella and Hypericum perforatum extracts and its antidepressant action
11/10/2004	CN1543964A Application in antidepressants preparation of asiatic acid and derivation
11/10/2004	CN1543961A Oxazepam dripping pills and preparation thereof
11/10/2004	CN1543960A Imipramine hydrochloride dripping pills and preparation
11/10/2004	CN1543959A Galantamin sustained release preparation and preparing process
11/10/2004	CN1543950A Hydroxyzine hydrochloride dripping pills and preparation thereof
11/10/2004	CN1543949A Dripping pills of isopropiram fumaratis and its preparation
11/10/2004	CN1543860A Method for extracting bamboo leaf flavonoid and foodstuff and drug containing the same
11/10/2004	CN1174984C Carbamoyl tetrahydropyridine derivatives
11/10/2004	CN1174979C Piperazine and piperidine compounds
11/10/2004	CN1174978C Heterocyclic compound as inhibitors of rotamase enzymes
11/10/2004	CN1174975C Benzopyrans compound and their use as therapeutic agent
11/10/2004	CN1174973C Schizonepeta lactone and its extraction process and use
11/10/2004	CN1174955C 3-amino-2-benzyl-1-phenyl-propane derivs.
11/10/2004	CN1174753C Improved copolymer-1 composed of copolymers
11/10/2004	CN1174745C Use of coating as taste masking agent for oral preparation
11/09/2004	US6815557 Tryptase inhibitors
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815469 Injectable liquid oligomer-polymer composition consisting of at least one bioactive substance, at least one solid polymeric hydroxycarboxylic acid ester and at least one liquid oligomeric hydroxycarboxylic acid ester
11/09/2004	US6815464 Halogenated 2-phenyl-1,2-ethanediol monocarbamate or dicarbamate derivatives; analgesics
11/09/2004	US6815463 For therapy of disease of cellular hyperproliferation in a subject
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815458 Nervous system disorders
11/09/2004	US6815456 Antiserotonine agents; central nervous system disorders
11/09/2004	US6815454 Percutaneously applicable preparation and suppository containing an antidementia medicament
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/09/2004	US6815448 For therapy of ognitive deficits due to aging, stroke, head trauma, alzheimer's disease or other neurodegenerative diseases, or schizophrenia; anxiety, aggression and stress, and for the control of various physiological phenomena
11/09/2004	US6815447 N-type calcium channel antagonists for the treatment of pain
11/09/2004	US6815446 Administering 8-amino-xanthine derivative as antiasthmatic or antidiarrhea agent
11/09/2004	US6815443 5-Amino-1-pentene-3-ol substituted derivatives
11/09/2004	US6815441 Reaction products of taurultam and glucose
11/09/2004	US6815438 Heteroaryl-diazabicycloalkanes
11/09/2004	US6815175 Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder
11/09/2004	US6814987 Compositions and methods of use for extracts of magnoliaceae plants
11/09/2004	US6814976 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
11/09/2004	US6814955 Aerosol comprises particles of chlordiazepoxide, betahistine, clonidine, testosterone, conjugated estrogens, estrogen esters, estradiol, estradiol esters, ethinyl estradiol, ethinyl estradiol esters, or hyoscyamine.
11/09/2004	US6814954 Delivery of compounds for the treatment of Parkinsons through an inhalation route
11/09/2004	CA2426781A1 Bace1 promoter sequences
11/09/2004	CA2144344C Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents
11/09/2004	CA2044853C Method for treating parkinson's disease employing an atp-sensitive potassium channel blocker
11/04/2004	WO2004095023A1 Novel method of screening
11/04/2004	WO2004094448A1 METHYLATED CpG POLYNUCLEOTIDE
11/04/2004	WO2004094433A1 New polymorphs of olanzapine hydrochloride
11/04/2004	WO2004094431A2 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
11/04/2004	WO2004094415A1 Risperidone monohydrochloride
11/04/2004	WO2004094414A1 Water soluble salts of risperidone
11/04/2004	WO2004094413A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004	WO2004094411A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors
11/04/2004	WO2004094408A1 Substituted pyrimidinones and pyrimidinthiones as crf antagonists
11/04/2004	WO2004094404A1 4-imidazolin-2-one compounds
11/04/2004	WO2004094384A2 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease
11/04/2004	WO2004094382A1 Muscarinic agonists
11/04/2004	WO2004094380A1 (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists
11/04/2004	WO2004094375A2 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
11/04/2004	WO2004094363A1 Muscarinic agonists
11/04/2004	WO2004093910A1 REMEDY FOR CEREBRAL NEURODEGENERATIVE DISEASES USING PPARδ AGONIST
11/04/2004	WO2004093893A2 Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques
11/04/2004	WO2004093882A1 Remedies for diseases to be applied to eye
11/04/2004	WO2004093867A2 Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
11/04/2004	WO2004093866A1 Process for preparing phenolic acid salts of gabapentin
11/04/2004	WO2004093857A1 Composition for relieving unpleasant symptoms accompanying change in protesterone
11/04/2004	WO2004093789A2 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/04/2004	WO2004083215A3 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications
11/04/2004	WO2004082584A3 5ht2c receptor antagonists in the treatment of schizophrenia
11/04/2004	WO2004082577A3 8-SUBSTITUTED-6, 7, 8, 9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES
11/04/2004	WO2004067703A3 5ht7 antagonists and inverse agonists
11/04/2004	WO2004067498A3 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/04/2004	WO2004065572A3 Proteic binding partners of tctp and methods of modulating tumor reversion or cell apoptosis
11/04/2004	WO2004064713A3 The use of yop preoteins or rho gtpase inhibitors as caspase-1 inhibitors
11/04/2004	WO2004058139A3 Use of istradefylline (kw-6002) for the treatment of behavioral disorders
11/04/2004	WO2004056774A3 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
11/04/2004	WO2004045592A3 Compounds and methods for increasing neurogenesis

1 ... 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 ... 1833